BACKGROUND: Recent experience with thyroidectomy for Graves' disease is limited. We report our current experience with thyroidectomy for Graves' disease at a tertiary hospital. METHODS: A prospective database showed 48 patients who underwent surgery for Graves' disease from April 1993 to June 2005. RESULTS: All patients had typical symptoms of Graves' disease. Twenty-three patients had ophthalmopathy. Indications for surgery were failed medical therapy (n = 24), presence of a dominant nodule (n = 12), or refusal of radioiodine (n = 12). Surgery included total thyroidectomy (n = 46) or subtotal thyroidectomy (n = 2). The incidence of cancer was 17%. Long-term follow-up data were available for 44 patients. No patients had recurrence of hyperthyroidism or cancer. Follow-up evaluation of 20 patients with ophthalmopathy showed the condition had either stabilized or resolved. CONCLUSIONS: Total thyroidectomy for Graves' disease offers rapid and durable control of hyperthyroidism, provides appropriate treatment for patients with coexisting cancer, and can stabilize or reverse ophthalmopathy.
BACKGROUND: Recent experience with thyroidectomy for Graves' disease is limited. We report our current experience with thyroidectomy for Graves' disease at a tertiary hospital. METHODS: A prospective database showed 48 patients who underwent surgery for Graves' disease from April 1993 to June 2005. RESULTS: All patients had typical symptoms of Graves' disease. Twenty-three patients had ophthalmopathy. Indications for surgery were failed medical therapy (n = 24), presence of a dominant nodule (n = 12), or refusal of radioiodine (n = 12). Surgery included total thyroidectomy (n = 46) or subtotal thyroidectomy (n = 2). The incidence of cancer was 17%. Long-term follow-up data were available for 44 patients. No patients had recurrence of hyperthyroidism or cancer. Follow-up evaluation of 20 patients with ophthalmopathy showed the condition had either stabilized or resolved. CONCLUSIONS: Total thyroidectomy for Graves' disease offers rapid and durable control of hyperthyroidism, provides appropriate treatment for patients with coexisting cancer, and can stabilize or reverse ophthalmopathy.
Authors: P V Pradeep; Amit Agarwal; Mukta Baxi; Gaurav Agarwal; Sushil Kumar Gupta; S K Mishra Journal: World J Surg Date: 2007-02 Impact factor: 3.352
Authors: Myrick C Shinall; James T Broome; Ratnam Nookala; Jennifer B Shinall; Colleen Kiernan; Lee Parks; Carmen C Solórzano Journal: Surgery Date: 2013-09-26 Impact factor: 3.982